City

New York (2)

East Melbourne (1)

Houston (1)

Louisville (1)

Omaha (1)

Perth (1)

Rochester (1)

Shanghai (1)

Vancouver (1)

Condition

Indolent Lymphoma (2)

Mantle Cell Lymphoma (2)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (1)

Follicular Lymphoma (1)

Hodgkin Lymphoma (1)

MALT Lymphoma (1)

Marginal Zone Lymphoma (1)

Refractory B-Cell Lymphoma (1)

Waldenstrom Macroglobulinemia (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Qilu Puget Sound Biotherapeutics (dba Sound Biologics) (1)

S*BIO (1)

Collaborator

Intervention

psb202 (1)

sb1518 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

Indolent Lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia Trial in Australia,

Recruiting

Follicular Lymphoma
+7 more

PSB202

Louisville, Kentucky
+4 more

Mar 11, 2022

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed

Hodgkin Lymphoma
+2 more

SB1518

Omaha, Nebraska
+4 more

Apr 19, 2012